Kuchynka P, Palecek T, Nemecek E, Kovarnik T, Horak J, Vitkova I and Linhart A
|
|
- Nicholas Casey
- 5 years ago
- Views:
Transcription
1 Is improvement of the left ventricular systolic function in patients with new-onset dilated cardiomyopathy related to the presence of virus or inflammation in endomyocardial biopsy? Kuchynka P, Palecek T, Nemecek E, Kovarnik T, Horak J, Vitkova I and Linhart A Department of Cardiovascular Medicine, General University Hospital, 1 st Faculty of Medicine, Charles University, Prague, Czech Republic Authors have no conflicts of interest
2 Viral Persistence and Prognosis patients (36 ± 18 years) - clinically susp. myocarditis tested by PCR - 31 (26%) viral genome + Caforio et al. Eur Heart J 2007;28:
3 Viral Persistence and Prognosis Kühl et al. Circulation 2005;112:
4 Viral Persistence and Prognosis patients (42 ± 15 years) - clinically susp. myocarditis - 79 (44%) PCR virus + Kindermann et al. Circulation 2008;118:
5 Viral Persistence and Prognosis Bock et al. N Engl J Med 2010;362:
6 Inflammation and Prognosis patients (42 ± 15 years) - clinically susp. myocarditis - 91 (50%) IH + Kindermann et al. Circulation 2008;118:
7 Inflammation and Prognosis patients (36 ± 18 years) - 85 active myocarditis - 89 borderline myocarditis lymfocytic myocarditis - 5 giant cell myocarditis - 7 other types Caforio et al. Eur Heart J 2007;28:
8 Aim of the Study To evaluate the significance of viral persistence and inflammation in endomyocardial biopsy in patients with new-onset unexplained DCM
9 Study Design Endomyocardial biopsy 110 subjects (53 ± 11 years, 34 women) with new-onset unexplained DCM - history of heart failure symptoms < 12 months - LVEF < 40% persisting after at least 2 weeks of conventional heart failure therapy
10 The Criteria of Unexplained DCM The absence of following: significant coronary artery disease moderate-to-severe primary valvulopathy significant congenital heart disease tachyarrhythmias; permanent pacemaker uncorrected metabolic or endocrine disorder history of alcohol or drug abuse history of cardiotoxic therapy family history of DCM
11 EMB Assessment Immunohistochemistry myocardial inflammation (Leucocytes > 14mm 2 and/or moderate/severe HLA-DR positivity) PCR Borrelia burgdorferi (Bb) PCR cardiotropic viruses: - herpetic viruses (HSV, EBV, CMV, HHV-6) - enteroviruses - parvovirus B-19 - adenovirus
12 Baseline Characteristics Heart Failure Symptoms + ECG Duration of symptoms 2,3 ± 2,0 months NYHA (I/II/III/IV) 0/12/50/48 Sinus rhythm 98 (89%) Atrial fibrillation 12 (11%) LBBB 21 (19%) RBBB 3 (3%) ST-T changes 46 (42%)
13 Baseline Characteristics Echocardiography LVEDD (mm) 68 ± 7 LVESD (mm) 58 ± 8 LVEF (%) 28 ± 7 LAV (ml) 101 ± 35 RV (mm) 37 ± 6 TAPSE (mm) 18 ± 4 PASP (mmhg) 42 ± 10 MR (1-4+) 34/61/13/2
14 EMB Results - I Immunohistochemistry + 35 (32%) Virus or Borrelia burgdorferi + 70 (64%) Virus + 56 (51%) Negative EMB 32 (29%)
15 EMB Results - II Borrelia burgdorferi 22 (20%) Parvovirus B of 88 (19%) > 500 ge/μg DNA 5 (29%) HHV-6 16 (15%) Enterovirus 8 (7%) HSV-1 4 (4%) CMV 3 (3%) Adenovirus 0 (0%)
16 EMB Results - III % 13 12% 22 20% 32 29% PCR virus + Immunohistochemistry - PCR virus + Immunohistochemistry + PCR virus - Immunohistochemistry + PCR virus - Immunohistochemistry - 0
17 Virus + / Immunohistochemistry ± Patients (27 patients with follow-up 6 months) Baseline 6 months F-U p LVEDD 65 ± 7 62 ± 7 LVESD 56 ± 7 50 ± 9 EF 29 ± 7 43 ± 10 LAV 101 ± ± 34 MR 1,6 ± 0,7 1,4 ± 0,6 TAPSE 18 ± 4 21 ± 4 NS PASP 41 ± ± 12 NS
18 Virus+ / Immunohistochemistry- Patients (14 patients with follow-up 6 months) Baseline 6 months F-U p LVEDD 63 ± 5 61 ± 4 NS LVESD 54 ± 6 48 ± 8 EF 29 ± 7 43 ± 12 LAV 108 ± ± 31 NS MR 2,0 ± 0,7 1,6 ± 0,7 TAPSE 17 ± 3 21 ± 3 PASP 45 ± ± 12 NS
19 Virus+ / Immunohistochemistry+ Patients (13 patients with follow-up 6 months) Baseline 6 months F-U p LVEDD 62 ± 9 59 ± 6 LVESD 59 ± 6 51 ± 9 EF 28 ± 6 42 ± 8 LAV 96 ± ± 36 NS MR 1,3 ± 0,5 1,2 ± 0,5 NS TAPSE 19 ± 5 20 ± 5 NS PASP 36 ± 7 35 ± 12 NS
20 EMB negative Patients (27 patients with follow-up 6 months) Baseline 6 months F-U p LVEDD 70 ± 7 65 ± 8 LVESD 59 ± 8 54 ± 9 EF 29 ± 8 40 ± 12 LAV 109 ± ± 21 MR 1,6 ± 0,7 1,4 ± 0,6 TAPSE 17 ± 4 21 ± 5 PASP 42 ± ± 6
21 EF % EMB+ vs. EMB- Patients (only conventional heart failure therapy) p=ns p 43±10 p 40 ±7 EMB positive patients n= ±7 29±7 EMB negative patients n= Baseline 6 M Baseline 6 M
22 Conclusions - I Microbial agent and/or inflammation are present in most patients with new-onset unexplained DCM (high prevalence of inflammatory cardiomyopathy). Conventional heart failure therapy is associated with similar improvement of LV EF in patients with new-onset DCM regardless the presence or absence of viral agent.
23 Conclusions - II Our findings of similar improvement in LV systolic function in both (EMB positive and EMB negative) groups treated only by conventional heart failure therapy might be explained either due to: 1) low impact of viral persistence on prognosis of affected subjects 2) or by underdiagnosing of inflammatory DCM by current techniques.
24 Thank you very much for your attention!
U N I V E R S I T Ä T S M E D I Z I N B E R L I N CBF KARDIOLOGIE
U N I V E R S I T Ä T S M E D I Z I N B E R L I N I have nothing to disclose. Case 2 A Case of acute heart failure 54 year old female Patient with acute heart failure and ventricular tachycardia 53 year
More informationMyocarditis in Infants and Children
in Infants and Children Guideline of the German Society of Pediatric Cardiology Thomas Paul, Carsten Tschöpe, Reinhard Kandolf Children s Heart Center, Georg-August-University, Göttingen Department of
More informationMyocarditis update. Standard therapy in 2017
Myocarditis update Standard therapy in 2017 Carsten Tschöpe, Berlin Charite, CVK Pathogenesis of viral myocarditis Blauwet L et al, Pro Cardiovascu Dis 2010 Spontaneous Course of biopsy proven MC/DCMi
More information4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification
Cardiomyopathy John Steuter, MD Bryan Heart Disclosures No Conflicts Cardiomyopathy WHO Classification Anatomy & physiology of the LV 1. Dilated Enlarged Systolic dysfunction 2. Hypertrophic Thickened
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationXVth Balkan Congress of Radiology Danubius Hotel Helia, October 2017, Budapest, Hungary
XVth Balkan Congress of Radiology Danubius Hotel Helia, 12-14 October 2017, Budapest, Hungary Ružica Maksimović MRI in Myocarditis Faculty of Medicine, University of Belgrade, Centre for Radiology and
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationMyocardites aigües MYOCARDITIS. 71 ème Journée Française de Médecine. Jean-Noël Trochu Institut du Thorax CHU de Nantes
Plain definition: MYOCARDITIS inflammation of the myocardium Myocardites aigües 71 ème Journée Française de Médecine Jean-Noël Trochu Institut du Thorax CHU de Nantes But numerous classification schemes:
More informationSevere Myocarditis: A 2012 update
Severe Myocarditis: A 2012 update Alain Combes Service de Réanimation ican, Institute of Cardiometabolism and Nutrition Hôpital Pitié-Salpêtrière, AP-HP, Paris Université Pierre et Marie Curie, Paris 6
More informationU N I V E R S I T Ä T S M E D I Z I N B E R L I N CBF KARDIOLOGIE
U N I V E R S I T Ä T S M E D I Z I N B E R L I N Inflammatory Cardiomyopathy Diagnosis and Treatment H.-P. Schultheiss Charité Universnflammatorische itätsmedizin Berlin Campus Benjamin Franklin Med.
More informationU N I V E R S I T Ä T S M E D I Z I N B E R L I N CBF KARDIOLOGIE
U N I V E R S I T Ä T S M E D I Z I N B E R L I N The Patient with Myocarditis Prof. Dr. Heinz-Peter Schultheis Med. Klinik II Kardiologie u. Pulmonologie Charité Campus Benjamin Franklin Berlin, Germany
More informationHeart Failure. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
Heart Failure Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction Uwe Kühl, PhD; Matthias Pauschinger, MD; Bettina Seeberg, MD; Dirk Lassner, PhD; Michel Noutsias, MD;
More informationCARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology
CARDIOMYOPATHY IN CT Hans- Christoph Becker Professor of Radiology 1 Cardiomyopathy Heart muscle disease Deterioration of the heart function, heart failure Dyspnea, peripheral edema Risk of arrhythmia,
More informationImaging in dilated cardiomyopathy : factors associated with a poor outcome
Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with
More informationDELAYED ENHANCEMENT IMAGING IN CHILDREN
NASCI 38 TH ANNUAL MEENG, SEATLE October 3-5, 21 1. DELAYED ENHANCEMENT IN CHILDREN Shi-Joon Yoo, MD Lars Grosse-Wortmann, MD University of Toronto Canada -1. 1. 1. Magnitude image Magnitude images -1.
More informationGranulomatous Myocarditis - An overlooked cause of cardiomyopathy
Granulomatous Myocarditis - An overlooked cause of cardiomyopathy C.Narasimhan CARE Hospital Hyderabad.India. Feb 2015, Medanta, New Delhi Outline: Background Our experience ( When to suspect, How to confirm)
More informationC. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra
C. Lutman, L. Vitali Serdoz, G. Barbati, E. Cadamuro, S. Magnani, M. Zecchin, M. Merlo, G. Sinagra Cardiovascular Department, Ospedali Riuniti and University, Trieste, Italy PURPOSE Sex differences exist
More informationTwo Decades of Managing Myocarditis. Peter C. Laussen MB.BS., FCICM
Two Decades of Managing Myocarditis Peter C. Laussen MB.BS., FCICM No disclosures Etiology Viral infections Epidemiologic change over time: Enteroviruses: 1970 s & 80 s Coxsackie group Adenovirus: 1990
More informationRight Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa
Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa 1 Ojji Dike B, Lecour Sandrine, Atherton John J, Blauwet Lori A, Alfa Jacob, Sliwa
More informationTHE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS
88 th ASMA ANNUAL SCIENTIFIC MEETING DENVER - CO April 30- May 4, 2017 THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS S. BISCONTE (1), J. MONIN (2), N. HUIBAN (3), G. GUIU (2), S. NGUYEN (1), O.
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationHighlights from EuroEcho 2009 Echo in cardiomyopathies
Highlights from EuroEcho 2009 Echo in cardiomyopathies Bogdan A. Popescu University of Medicine and Pharmacy, Bucharest, Romania ESC Congress 2010 Hypertrophic cardiomyopathy To determine the differences
More informationDiagnostic approach of myocarditis: strike the golden mean
Neth Heart J (2014) 22:80 84 DOI 10.1007/s12471-013-0499-3 ICIN Diagnostic approach of myocarditis: strike the golden mean M. R. Hazebroek K. Everaerts S. Heymans Published online: 8 January 2014 # The
More informationImaging and heart failure
Imaging and heart failure Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston, St Jude, BMS imaging, GE Healthcare,
More informationCLINICAL/THERAPEUTIC APPROACHES TO THREE SPECIFIC CARDIOMYOPAHIES: MYOCARDITIS, AMYLOIDOSIS, AND NON-COMPACTION
CLINICAL/THERAPEUTIC APPROACHES TO THREE SPECIFIC CARDIOMYOPAHIES: MYOCARDITIS, AMYLOIDOSIS, AND NON-COMPACTION G. William Dec, MD, FACC Massachusetts General Hospital Harvard Medical School American College
More informationEchocardiographic Correlates of Pulmonary Artery Systolic Pressure
Echocardiographic Correlates of Pulmonary Artery Systolic Pressure The Role of Left Ventricular Diastolic Function Yoram Agmon MD, Shemy Carasso MD, Diab Mutlak MD, Jonathan Lessick MD Dsc, Izhak Kehat
More informationRole of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan
Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo
More informationEchocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction
Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none
More informationDesmin expression in cardiomyocytes - a good predictor of development of chronic heart failure.
Desmin expression in cardiomyocytes - a good predictor of development of chronic heart failure. Department of Invasive Cardiology, Central Hospital of Internal Affairs and Administration Ministry, Warsaw,
More informationImportance of CRT team for optimization of the results: a European point of view
Importance of CRT team for optimization of the results: a European point of view Matteo Bertini, MD, PhD Arcispedale S. Anna Azienda Ospedaliero-Universitaria Cona-Ferrara No conflict of interest to declare
More informationFollowing viral myocarditis, which athlete can re-enter his active sports career?
Following viral myocarditis, which athlete can re-enter his active sports career? ESC Congress 2011 Paris F. Carré University Rennes 1-Pontchaillou Hospital Inserm U642, Rennes - F-35000 The author declares
More informationCRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT?
CRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT? Alessandro Lipari, MD Chair and Department of Cardiology University of Study and Spedali Civili Brescia -Italy The birth of CRT in Europe, 20 years ago
More informationLV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION
LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:
More informationMyocarditis Bugs, Drugs, and the Role of Mechanical Circulatory Support
Myocarditis Bugs, Drugs, and the Role of Mechanical Circulatory Support Matthew J. Bock, M.D. Assistant Professor, Division of Pediatric Cardiology Pediatric Heart Failure & Transplantation Loma Linda
More informationCardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine
Jens Bremerich Radiology University Hospital Basel Hypertrophic Obstructive Cine VENC Cine (5m/s) Modified Bernoulli Equation: P (in mmhg) = 4 x (Vmax)2 Vmax= 4.2 m/s, P = 70mm Hg Hydrodynamica 738 HOCM
More informationHigh Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With Idiopathic Left Ventricular Dysfunction
High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With Idiopathic Left Ventricular Dysfunction Uwe Kühl, PhD, MD; Matthias Pauschinger, MD; Michel Noutsias, MD;
More informationMyocarditis. By : Nader Alaridah MD,PhD
Myocarditis By : Nader Alaridah MD,PhD Background Myocarditis is an inflammatory disease of the cardiac muscle. Histologically, It is described as an inflammatory infiltrate of the myocardium with necrosis
More informationThe Study of Congenital Infections. A/Prof. William Rawlinson Dr. Sian Munro
The Study of Congenital Infections A/Prof. William Rawlinson Dr. Sian Munro Current Studies SCIP Study of Cytomegalovirus (CMV) Infection in Pregnancy ASCI Amniotic Fluid Study of Congenital Infections
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationControversies in myocarditis
Controversies in myocarditis Virus persistence is relevant: contra Prof.dr. Stephane Heymans Dep. Cardiology, CARIM/Maastricht University (Parvo)virus persistence marks the failing heart Chicken or the
More informationAssociation between RV Function in PPCM and LV Recovery & Clinical Outcome
Association between RV Function in PPCM and LV Recovery & Clinical Outcome Lori A Blauwet, MD, MA Associate Professor of Medicine Co-Director, Cardio-OB Clinic Mayo Clinic Rochester, MN USA 2016 MFMER
More informationRest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome
Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome G. Deswarte, AS. Polge, N. Lamblin, A. Millaire, M. Richardson, C. Bauters,
More informationManagement of myocarditis: Update J. Parissis Athens, GR
Management of myocarditis: Update 2018 J. Parissis Athens, GR 1980: First review on etiopathogenesis (Coxsackie viruses, immune system) 1985: Dallas criteria 1987: Cardiac autoantibodies in mouse model
More informationPathophysiology. Myocarditis & inflammatory cardiomyopathy DEFINITIONS. Andre Keren, MD
Myocarditis & Inflamatory Cardiomyopathy Andre Keren, MD Director, the Heiden Dept of Cardiology Bikur Cholim Hospital Jerusalem, Israel DEFINITIONS MYOCARDITIS: inflamatory infiltrate of of the myocardium
More informationTachycardia-induced heart failure - Does it exist?
Tachycardia-induced heart failure - Does it exist? PD Dr Etienne Delacrétaz Clinique Cecil et Hôpital de Fribourg SSC Cardiology meeting 2015 Zürich Rapid atrial fibrillation is a common cause of heart
More informationJournal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00648-x
More informationRestrictive Cardiomyopathy
ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures
More informationIndications for and Prediction of Successful Responses of CRT for Patients with Heart Failure
Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Edmund Keung, MD Clinical Chief, Cardiology Section San Francisco VAMC October 25, 2008 Presentation Outline
More informationThoranis Chantrarat MD
Device Therapy in Heart Failure Thoranis Chantrarat MD 1 Scope of presentation Natural history of heart failure Primary and secondary prevention ICD and its indication CRT and its indication 2 Severity
More informationDevelopment of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis
See Editorial, p 685 1 Department of Cardiology and Pneumonology, CharitéeUniversity Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany 2 Robert Koch nstitute Berlin, Berlin, Germany 3 nterdisciplinary
More informationHeart failure for syndicate
Heart failure for syndicate By M.Wafaie Aboleineen,MD,FACC ESC Guidelines for the diagnosis and treatment of heart failure Part I 1 4 2 Common ECG abnormalities in HF 3 Common CXR abnormalities in HF Common
More informationCase Report Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella CP): A Rare Case
Hindawi Volume 2017, Article ID 9231959, 4 pages https://doi.org/10.1155/2017/9231959 Case Report Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella CP): A Rare Case Henrik Fox, Martin
More informationLeft ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy
Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania My conflicts of interest: I have
More informationCardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI
Cardiomyopathy ACOI IM Board Review 2018 Martin C. Burke DO, FACOI No Disclosures Cardiomyopathies Definition: diseases of heart muscle 1980 WHO: unknown causes Not clinically relevant 1995 WHO: diseases
More information2
1 2 Although the term "cardiomyopathy" could theoretically apply to almost any disease affecting the heart, it is usually reserved for "severe myocardial disease leading to heart failure".cardiomyopathy
More informationHeart rate lowering treatment in chronic heart failure
Heart rate lowering treatment in chronic heart failure Jaromir Hradec 3rd Dept. Med., Charles Univ., Prague Czech Republic Things we knew, things we did Things we have learnt, things we should do What
More informationISOLATED ANOMALOUS DEVELOPMENT OF MYOCARDIUM DURING FETAL LIFE: EXPERIENCE OF OUR CENTRE
Azienda Ospedaliera Universitaria Integrata Verona ISOLATED ANOMALOUS DEVELOPMENT OF MYOCARDIUM DURING FETAL LIFE: EXPERIENCE OF OUR CENTRE C.Sandrini *, L.Rossetti *, M.Rebonato *, M.A.Prioli *, F.Bettinazzi,
More informationSleep Apnea and Heart Failure
Sleep Apnea and Heart Failure Micha T. Maeder, MD Cardiology Division Kantonsspital St. Gallen Switzerland micha.maeder@kssg.ch Sleep Disordered Breathing (SDB) in HFrEF 700 HFrEF patients (LVEF
More informationNew Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD
New Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD Professor of Medicine, Cell Biology, Radiology and Surgery Director, The Howard Gilman Institute for Heart Valve Disease and the Schiavone
More informationEchocardiography in Adult Congenital Heart Disease
Echocardiography in Adult Congenital Heart Disease Michael Vogel Kinderherz-Praxis München CHD missed in childhood Subsequent lesions after repaired CHD Follow-up of cyanotic heart disease CHD missed in
More informationCardiac Resynchronization Therapy for Heart Failure
Cardiac Resynchronization Therapy for Heart Failure Ventricular Dyssynchrony vs Resynchronization Ventricular Dysynchrony Ventricular Dysynchrony 1 Electrical: Inter- or Intraventricular conduction delays
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationEvaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death
Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death Presenters: Sabrina Phillips, MD FACC FASE Director, Adult Congenital Heart Disease Services The University of Oklahoma
More informationMyocarditis is the term used to indicate infectious, toxic,
Parvovirus B19 Infection Mimicking Acute Myocardial Infarction Uwe Kühl, MD, PhD; Matthias Pauschinger, MD; Thomas Bock, MD; Karin Klingel, MD; C. Peter Lothar Schwimmbeck, MD; Bettina Seeberg; Lars Krautwurm;
More informationDegenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention
Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral
More informationDilated cardiomyopathies. Gene mutations and beyond.
Dilated cardiomyopathies. Gene mutations and beyond. Stephane Heymans Dep. of Cardiology, CARIM, Maastricht University Medical Centre, www.hfresearch.eu Ward Heggermont Job Verdonschot Mark Hazebroek George
More informationPRESENTER DISCLOSURE INFORMATION. There are no potential conflicts of interest regarding current presentation
PRESENTER DISCLOSURE INFORMATION There are no potential conflicts of interest regarding current presentation Better synchrony and diastolic function for septal versus apical right ventricular permanent
More informationAlcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. CardioVascular Research Foundation
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Alcohol Septal Ablation (ASA) Nonsurgical technique for septal myocardial reduction Dramatic hemodynamic improvement Technically easy
More informationExercise PHT in valvular heart disease. Julien Magne CHU Limoges, France
Exercise PHT in valvular heart disease Julien Magne CHU Limoges, France Faculty disclosure Julien Magne I disclose the following financial relationships: I have no financial relationships to disclose.
More informationPrevalence of heart failure in Turkish adult population: Results from Heart failure Prevalence and Predictors in TurkeY (HAPPY) study
Prevalence of heart failure in Turkish adult population: Results from Heart failure Prevalence and Predictors in TurkeY (HAPPY) study M. Degertekin, Ç. Erol O. Ergene, Ö. Kozan, B. Mutlu, E. Ilkay, E.
More informationGender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy
Electrophysiology Gender and cardiac resynchronization therapy Dean Boddington Chairs: David Heaven & Belinda Green Gender and Cardiac Resynchronisation Therapy Dean Boddington Tauranga Hospital 1 Disclosure/Warning
More informationΔυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;
Ελληνική Καρδιολογική Εταιρεία Σεμινάρια ομάδων εργασίας Θεσσαλονίκη, 8-10 Φεβρουαρίου 2018 Ομάδα εργασίας Ηχωκαρδιολογίας Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ; ΑΓΑΘΗ-ΡΟΖΑ
More informationHis Bundle Pacing in Bundle Branch Block May 11, 2017
His Bundle Pacing in Bundle Branch Block May 11, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac EP Program Director, IUH Atrial Fibrillation Center Assistant Professor of Clinical Medicine
More informationQCVC Committees Scientific Activities Central Hall General Information FAC. SPECT tomography has the advantage of quantifying biventricular volumes.
QCVC Committees Scientific Activities Central Hall General Information FAC Thematic Units Arrhythmias and Electrophysiology Basic Research Bioengineering and Medical Informatics Cardiac Surgical Intensive
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationAtrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction
Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction JC Eicher, G Laurent, O Barthez, A Mathé, G Bertaux, JE Wolf Heart Failure Treatment Unit, Rhythmology and
More informationMANAGEMENT OF ASYMPTOMATIC BRADYCARDIA. Pr. HABIB HAOUALA Service de Cardiologie Hôpital militaire de Tunis
MANAGEMENT OF ASYMPTOMATIC BRADYCARDIA Pr. HABIB HAOUALA Service de Cardiologie Hôpital militaire de Tunis DISCLOSURE STATEMENT OF FINANCIAL INTEREST Grant/research: Medtronic;Sanofi; Novartis Consulting
More informationDeclaration of conflict of interest. I have nothing to disclose.
Declaration of conflict of interest I have nothing to disclose. Left Bundle branch block in HF: DO GENETICS MATTER? Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University
More informationThe role of endomyocardial biopsy in the management of cardiovascular disease
European Heart Journal (2007) 28, 3076 3093 doi:10.1093/eurheartj/ehm456 AHA/ACCF/ESC scientific statement The role of endomyocardial biopsy in the management of cardiovascular disease A Scientific Statement
More informationNonpharmacologic Treatment of Ventricular Heart Failure
Nonpharmacologic Treatment of Ventricular Heart Failure Hong Ryang Kil, MD, PhD Department of Pediatrics, College of Medicine, Chungnam National University 2001 AHA Guideline for CHF - Symptomatic LV dysfunction
More informationReturn to work in heart failure patients with suspected viral myocarditis
Humanwissenschaftliche Fakultät Rona Reibis Uwe Kühl Annett Salzwedel Mortesa Rasawieh Sarah Eichler Karl Wegscheider Heinz Völler Return to work in heart failure patients with suspected viral myocarditis
More informationReport Documentation Page
Clinical and Pathologic Characteristics of Myocarditis as a Cause of Sudden Death Lena Avedissian, Jennifer A. McNear, David A. Appel, Laudino M. Castillo Rojas, J. Edwin Atwood, Lisa A. Pearse, Robert
More informationTreatment of VT of Purkinje fiber origin: ablation targets and outcome
Treatment of VT of Purkinje fiber origin: ablation targets and outcome Ch. Piorkowski University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany Presenter Disclosure Information Gerhard
More informationECHO HAWAII. My home. Pulmonary Hypertension and Pulmonary Embolism: Role of Echo U.S.A. Japan. Hawaii Island 1/9/2018
Pulmonary Hypertension and Pulmonary Embolism: Role of Echo ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan My home Japan U.S.A Hawaii Island 1 Economy
More informationMyocarditis in Pregnancy
Myocarditis in Pregnancy Avraham Shotan Heart Institute, Hillel Yaffe Medical Center, Hadera, Israel Myocarditis Definition An inflammatory disease of the myocardium diagnosed by established histological,
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationTrials Enrolled subjects Findings Fox et al. 2014, SIGNIFY 1
Appendix 5 (as supplied by the authors): Published trials on the effect of ivabradine on outcomes including mortality in patients with different cardiovascular diseases Trials Enrolled subjects Findings
More informationIs it HF secondary to rheumatic heart disease???
Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle
More informationSix months later was hospitalized for classical LVF -PND / orthopnoea - which rapidly progressed to class IV - with systemic venous congestion -
HISTORY 48 years female, on Metformin with history of Diabetes Mellitus was diagnosed to have asymptomatic LV Dysfunction (with normal CAG) during pre-operative evaluation - for scapular injuryin RTA.
More informationESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309
ESC Guidelines Update 2008 ESC Guidelines Heart failure update 2008 For internal training purpose. 0 Agenda Introduction Classes of recommendations Level of evidence Treatment algorithm Changes to ESC
More informationGuideline Number: NIA_CG_320 Last Revised Date: July, 2018 Responsible Department: Implementation Date: January 2019 Clinical Operations
National Imaging Associates, Inc. Clinical guidelines CARDIAC RESYNCHRONIZATION THERAPY (CRT) CPT Codes: 33221, 33224, 33225, 33231 Original Date: February, 2013 Page 1 of 10 Last Review Date: March 2017
More informationHis Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017
His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,
More informationWhat s New in Cardiac MRI
What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures
More informationLarge RCT s of CRT 2002 to present
Have We Expanded Our Use of CRT for Heart Failure Patients? Sana M. Al-Khatib, MD, MHS Associate Professor of Medicine Electrophysiology Section- Division of Cardiology Duke University Potential Conflicts
More informationValvular Guidelines: The Past, the Present, the Future
Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,
More informationReview. Myocarditis. Gabriel Fung, Honglin Luo, Ye Qiu, Decheng Yang, Bruce McManus
Review Myocarditis Gabriel Fung, Honglin Luo, Ye Qiu, Decheng Yang, Bruce McManus Abstract: Viral myocarditis remains a prominent infectious-inflammatory disease for patients throughout the lifespan. The
More informationCorrespondence should be addressed to Tor Skibsted Clemmensen;
Case Reports in Transplantation, Article ID 173589, 4 pages http://dx.doi.org/10.1155/2014/173589 Case Report Case of Acute Graft Failure during Suspected Humoral Rejection with Preserved Ejection Fraction,
More information